CHRISTOPHER CAULFIELD: Open Payments
NPI 1942842307 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 14 payments from 10 companies in 2025. Trend: 2023 $41 · 2024 $0 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $285 |
| Ethicon US, LLC | 1 | $103 |
| Edwards Lifesciences Corporation | 1 | $65 |
| Actelion Pharmaceuticals US, Inc. | 2 | $53 |
| Abbott Laboratories | 1 | $47 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Boston Scientific Corporation | 1 | $21 |
Products named: AURORA EV-ICD MRI SURESCAN, SURGIFLO Hemostatic Matrix, SAPIEN 3 Ultra RESILIA, PENTA, LINQ II, OPSUMIT, INSPIRE, OPSYNVI.
Industry payments across MD — which companies pay providers there.
